The independent platform for news, articles and advice for professionals in laboratory medicine

Apheresis system to aid expansion of sickle cell disease treatment

Terumo Blood and Cell Technologies has announced that NHS England has selected the automated red blood cell exchange (RBCX) procedure performed on the company’s Spectra Optia Apheresis System to treat sickle cell disease.

As a result of this decision, Spectra Optia will be deployed more widely in hospitals across England. This will enable sickle cell disease patients to have improved access to this life-changing treatment.

“Sickle cell disease (SCD) is a group of inherited red blood cell disorders that can result in unbearable pain and the need for emergency hospitalisation,” said Antoinette Gawin (CEO, Terumo Blood and Cell Technologies). “Specific ethnic minorities suffering from sickle cell disease are an underserved group of patients due to historical health inequalities. We have used Spectra Optia to target sickle cell disease to help address some of these inequalities.

“Existing standards of care for sickle cell disease vary by region in England and often come with additional health complications that lead to higher costs and poor health outcomes. The Spectra Optia system will be used to help treat more patients across England far more cost-effectively.”

Sickle cell disease is one of the most common genetic conditions affecting people in England. There are currently over 12,000 patients receiving treatment in 68 different NHS hospitals. Forty per cent of those patients are under 20 years old. 

www.terumobct.com/

 

Upcoming Events

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025